M3 (2413) FY2027 Q1 Earnings Report

Quick View

Executive Summary

Despite higher revenue, this was a financial quarter in which both operating income and net income declined due to a lower gross profit margin and higher expenses. Revenue increased to ¥901.0B (+4.5% YoY), but operating income fell substantially to ¥180.8B (-8.6%), while net income attributable to owners of the parent declined significantly to ¥90.7B (-23.4%). The primary factors behind the decline in operating income were the lower gross profit margin resulting from a higher cost-of-sales ratio (49.3%, compared with 51.7% in the same period last year) and SG&A expenses, which increased faster than revenue (+6.7%). In addition, the higher effective tax rate (43.2%) amplified the decline in net income.

Factors Affecting Business Performance

【Revenue】Revenue increased 4.5% YoY to ¥901.0B. Overseas (¥227.4B, +9.7%), Patient Solutions (¥147.5B, +9.9%), and Site Solutions (¥141.6B, +9.0%) led growth, while Evidence Solutions (¥56.4B, -8.5%) and Career Solutions (¥79.8B, -3.6%) recorded declines in revenue. Growth in the core Medical Platform (¥243.8B) slowed to +0.9%.

【Profit and Loss】Operating income declined 8.6% YoY to ¥180.8B. The gross profit margin fell to 49.3% from 51.7% in the same period last year, while SG&A expenses increased 6.7% to ¥278.1B, outpacing revenue growth. Although equity-method investment gains of ¥15.3B (¥10.4B in the same period last year) and a return to a positive net financial result of ¥5.6B (compared with an excess of expenses of ¥0.9B in the same period last year) provided support, profit before tax remained at ¥186.4B (-5.3%). Due to the increased income tax burden of ¥80.6B (¥61.5B in the same period last year), net income declined to ¥105.8B (-21.8%), while net income attributable to owners of the parent fell ¥90.7B (-23.4%), resulting in a larger decline. In conclusion, the company achieved revenue growth but suffered a decline in profit.

Segment Analysis

Of the total reported segment profit of ¥187.3B, Medical Platform remained the largest pillar at ¥88.7B (47.4% of the total, 36.4% profit margin), almost unchanged at -1.2% YoY. Career Solutions maintained a 45.1% profit margin despite declining revenue, demonstrating the highest profitability among the reported segments. Meanwhile, although Site Solutions increased revenue by +9.0%, profit declined 97.9% to ¥0.1B from ¥7.3B in the same period last year, with the profit margin falling to 0.1%. Overseas operations recorded higher revenue (+9.7%) but lower profit of ¥46.1B (-4.9%), resulting in a decline in the profit margin to 20.3%. Evidence Solutions also experienced deteriorating profitability, with profit declining 33.1%. The sharp deterioration in the profitability of Site Solutions has been a factor pushing down the company-wide operating profit margin.

Key Financial Metrics

【Profitability】The operating profit margin was 20.1%, down 2.9pt from 22.9% in the same period last year. The net profit margin, based on net income attributable to owners of the parent, was 10.1%, down 3.7pt from 13.7% in the same period last year. The lower gross profit margin (49.3%, compared with 51.7% in the same period last year) and increased tax burden placed pressure on profitability. 【Cash Quality】Although operating cash flow has not been disclosed, EBITDA, including depreciation and amortization of ¥43.5B, was approximately ¥224B, implying an EBITDA margin of approximately 24.9%. Accounts receivable declined to ¥699.3B from ¥746.2B at the end of the previous fiscal year, indicating an improving trend in receivables collection. 【Investment Efficiency】Annualized ROE was 9.5%. Basic EPS was ¥13.60, down -22.0% from ¥17.44 in the same period last year. BPS was ¥605.97, a slight decrease from ¥608.98 at the end of the previous fiscal year. 【Financial Soundness】The equity ratio remained at 64.0%, at the same level as in the same period last year. Cash and cash equivalents stood at ¥1621.7B. Against long-term borrowings of ¥325.9B, short-term borrowings were limited to ¥49.7B, indicating a conservative financial foundation.

Cash Flow Analysis

Although disclosed figures from the statement of cash flows are unavailable, cash trends can be assessed based on changes in the balance sheet. Cash and cash equivalents increased by ¥59.7B to ¥1621.7B from ¥1561.8B at the end of the previous fiscal year. Accounts receivable declined by ¥46.9B to ¥699.3B from ¥746.2B at the end of the previous fiscal year, while accounts payable declined by ¥18.5B to ¥562.2B from ¥580.7B. From a working capital perspective, the decline in receivables may have contributed to cash generation. At the same time, ¥170.9B in dividends from retained earnings (¥146.8B attributable to owners of the parent and ¥24.1B attributable to non-controlling interests) represented an outflow of capital. The increase in cash despite funding these shareholder returns suggests that the business maintained a certain level of cash-generating capacity.

Quality of Earnings

Operating income of ¥180.8B included equity-method investment gains of ¥15.3B (¥10.4B in the same period last year), contributing ¥4.9B to the YoY increase. Other income of ¥3.6B and other expenses of ¥4.7B resulted in other net expenses of ¥1.1B, a deterioration of ¥3.3B from other net income of ¥2.2B in the same period last year, thereby weighing on operating income. Financial income of ¥8.6B represented 1.0% of revenue, indicating limited dependence on non-operating income. The ¥80.6B difference between profit before tax of ¥186.4B and net income of ¥105.8B consisted mainly of income taxes. Net income attributable to owners of the parent of ¥90.7B represented only 51.3% of profit before tax. The effective tax rate was 43.2%, above the normal level, and the increased tax burden was the primary factor reducing the quality of earnings for the current period. Comprehensive income was ¥140.8B, exceeding net income of ¥105.8B, partly due to foreign exchange factors such as foreign currency translation adjustments for foreign operations of ¥22.6B. However, this does not indicate the company’s operating cash-generating capacity.

Earnings Forecast and Guidance

The full-year company plan calls for revenue of ¥4000.0B, operating income of ¥800.0B (+8.8% YoY), and net income of ¥560.0B (+7.9% YoY). Q1 progress rates were 22.5% for revenue, 22.6% for operating income, and approximately 18.9% for consolidated net income. All were below the standard progress rate of 25%, although none deviated by more than 10 percentage points. The Q1 operating profit margin of 20.1% was broadly consistent with the assumed full-year plan margin of 20.0%, indicating that the company was generally maintaining the pace required to achieve its operating targets. On the other hand, Q1 net income declined 21.8% YoY, whereas the full-year plan assumes an increase in profit. Normalization of the tax burden and improved profitability in the second half are therefore prerequisites for achieving the plan.

Shareholder Returns

The dividend forecast for the fiscal year ending March 2027 has not yet been determined. The company has indicated that it will make a decision after considering future funding needs and cash flow conditions. During Q1, ¥146.8B was paid as dividends to owners of the parent. However, this payment was funded by prior-period earnings and other sources, making it inappropriate to calculate the payout ratio by comparing it with quarterly net income of ¥90.7B. Share repurchases were effectively zero in Q1, and there were no developments to evaluate in terms of the total return ratio, including share buybacks. The financial foundation of cash of ¥1621.7B and an equity ratio of 64.0% indicates flexibility in terms of the resources available when considering future shareholder return policies.

Risk Factors

1. Deterioration in the profitability of Site Solutions: The segment increased revenue to ¥141.6B (+9.0%), but operating income declined 97.9% to ¥0.1B from ¥7.3B in the same period last year. A structural profitability issue has emerged in which revenue growth is not translating into profit.

2. Pressure on net income from the high tax burden: The effective tax rate was high at 43.2%. While profit before tax declined -5.3%, net income declined -21.8% and net income attributable to owners of the parent declined -23.4%. It is necessary to determine whether this is a one-off factor or a structural issue.

3. Demand fluctuations by business area: Revenue from Evidence Solutions declined -8.5%, while revenue from Career Solutions declined -3.6%, indicating that fluctuations in clinical trial projects and demand for healthcare personnel are affecting earnings. Although the overseas business achieved revenue growth, its profit margin declined to 20.3%, reflecting the impact of foreign exchange rates and local cost trends.

Industry Benchmark (For Reference; Company Research)

Profitability and Returns

Both the operating profit margin and net profit margin significantly exceeded the industry median, placing the company’s profitability at a high level within the industry.

Growth and Capital Efficiency

The revenue growth rate was below the industry median, indicating that the company’s growth was relatively moderate within the industry.

※Source: Company research

Key Takeaways from the Earnings

1. The operating profit margin declined to 20.1% from 22.9% in the same period last year, but was broadly consistent with the assumed full-year company plan margin of 20.0%. As of Q1, the company is maintaining the profitability level required by the plan.

2. The decline in net income (-21.8%) significantly exceeded the decline in operating income (-8.6%). This divergence was primarily attributable to the higher effective tax rate. Confirming whether the tax burden is temporary or ongoing in subsequent quarters will be important in assessing the quality of earnings.

3. The sharp decline in Site Solutions’ segment profit (-97.9%) was one of the primary factors depressing the company-wide profit margin. The breakdown in the linkage between revenue growth and profit warrants close monitoring as an indication of the company’s earnings structure.

Theoretical Share Price (Reference Value)

Sensitivity: ¥664–¥703 at a ±1% change in the cost of equity, and ¥681–¥686 at a ±0.1 change in ω.

Notes:

• Goodwill represents a high proportion of net assets, and the assumptions would change significantly if impairment occurred.
• Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee the future share price.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with professionals as necessary.

---End of Report---